Work

1235 A phase-I study of the combination of intravenous reovirus (REOLYSIN ®) and gemcitabine in patients with advanced cancer

Year: 2009

Type: conference-abstract

Source: European Journal of Cancer Supplements

DOI: 10.1016/s1359-6349(09)70447-1

Authors: M.P. Lolkema, K. Harrington, J. Evans, H.T. Arkenau, P. Roxburgh, R. Morrison, V. Roulstone, M. Coffey, K. Mettinger, J. de Bono

Language: English

Topic: Virus-based gene therapy research

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2121763014

Cites:

Cited by: 1

Related to: 10